Curriculum Vitae Maarten Lambrecht
1Personal Information
Maarten Lambrecht
Date of birth: 07-07-1983
Place of birth: Amsterdam, Nederland
Email:
2Bibliography
Lambrecht M, Dirix P, Nuyts S. Incidence of isolated regional recurrences after definitive (chemo-)radiotherapy for HNSCC. RadiotherOncol 2009 Dec;93(3):498-502.
Lambrecht M, Dirix P, Vandecaveye V, De Keyzer F, Nuyts S. Role and value of diffusion-weighted MRI in the radiotherapeutic management of head and neck cancer. Expert Rev Anticancer Ther 2010;10:1451-1459.
Dirix P, Lambrecht M, Nuyts S. Radiotherapy for laryngeal squamous cell carcinoma: current standards. Expert Rev Anticancer Ther 2010;10:1461-1469.
Lambrecht M, Deroose C, Roels S, Vandecaveye V, Penninckx F, Sagaert X , Van Cutsem E. De Keyzer F, Haustermans K.The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancer. ActaOncologica 2010;49:956-963.
Lambrecht M, Haustermans K. Clinical evidence on PET-CT for radiation therapy planning in gastro-intestinal tumors. RadiotherOncol 2010;52:773-784.
Vandecaveye V, De Keyzer F, Dirix P, Lambrecht M, Nuyts S, Hermans R. Applications of diffusion-weighted magnetic resonance imaging in head and neck squamous cell carcinoma. Neuroradiology 2010;52:773-784.
Haustermans K, Debuquoy A, Lambrecht M. The ESTRO Breur Lecture 2010: towards a tailored patient approach in rectal cancer. RadiotherOncol 2011;100:15-21.
Lambregts D, Vandecaveye V, Barbaro B, Bakers F, Lambrecht M, Maas M, Haustermans K, Valentini V, Beets G, Beets-Tan R. Diffusion weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer. Ann SurgOncol 2011:18:2224-22231.
van Stiphout RG, Lammering G, Buijsen J, Janssen MH, Gambacorta MA, Slagmolen P, Lambrecht M, Rubello D, Gava M, Giordano A, Postma EO, Haustermans K, Capirci C, Valentini V, Lambin P. Development and external validation of a predictive model for pathological complete response of rectal cancer patients including sequential PET-CT imaging. RadiotherOncol 2011;98:126-133 Dec 20.
Lambrecht M, Vandecaveye V, De Keyzer F, Roels S, Penninckx F, Van Cutsem E, Haustermans K. The value of diffusion weighted MRI for the prediction of pathological response in rectal cancer treated with preoperative chemoradiotherapy. Int J radiatOncolBiol Phys 2012 Feb 1;82(2):863-70.
Vandecaveye V, Dirix P, De Keyzer F, Op de Beeck K, Van der Poorten V, Hauben E, Lambrecht M, Nuyts S, Hermans R. Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head and neck squamous cell carcinoma. Int J RadiatOncolBiol Phys 2012;82:1098-1107.
Lambrecht M, Nevens D, Nuyts S. Intensity-Modulated radiotherapy vs. parotid sparing 3D conformal radiotherapy: effect on outcome and toxicity in locally advanced head and neck cancer. StrahlentherOnkol 2013;189:223-229.
Lambrecht M, Mercier C, Geussens Y, Nuyts S. The effect of a supersaturated calcium phosphate mouth rinse on the development of oral mucositis in head and neck cancer patients treated with chemo/radiotherapy A single-center, randomized, prospective study of Caphosol® + standard of care versus standard of care. Support Care Cancer 2013; 21:2663-2670.
Nuyts S, Lambrecht M, Duprez F, Daisne J-F, Van den Weyngaert D, Platteaux N, Geussens Y, Voordeckers M, Madani I, De Neve W. Reduction of the dose to the elective neck in head and neck squamous cell carcinoma, a randomized clinical trial using intensity modulated radiotherapy (IMRT). Dosimetrical analysis and effect on acute toxicity. RadiotherOncol 2013;109:323-329.
Lambrecht M, Van Herck H, De Keyzer F, Vandecaveye V, Slagmolen P, Suetens P, Hermans R, Nuyts S. Redefining the target early during treatment. Can we visualize regional difference within the target volume using sequential diffusion weighted MRI? RadiotherOncol 2014;110:329-334.
Nelissen C, Lambrecht M, Nevens F, Van Raemdonck D, Vanhaecke J, Kuypers D, Pirenne J, Nuyts S. Noncutaneous head and neck cancer in solid organ transplant patients: single center experience. Oral Oncol. 2014;50:263-234.
Lambrecht M, Van Calster Ben, Vandecaveye Vincent, De Keyzer F, Roebben I, Hermans R, Nuyts S. Integratin pretreatment diffusion weighted MRI into a multivariable prognostic model for head and neck squamous cell carcinoma. RadiotherOncol 2014; 110:429-434.
Joye I, Lambrecht M, Jegou D, Hortobagyi E, Scalliet P, Haustermans K. Does a central review platform improve the quality of radiotherapy for rectal cancer? Results of a national quality assurance project. RadiotherOncol 2014;111:400-405.
Machiels JP, Lambrecht M, Hanin FX, Duprez T, Gregoire V, Schmitz S, Hamoir M. Advances in the management of squamous cell carcinoma of the head and neck. F1000Prime Rep 2014 Jun, 2;6:44.
Smet S, Lambrecht M, Vanstraelen B, Nuyts S.Clinical and dosimetric evaluation of RapidArc versus standard sliding window IMRT in the treatment of head and neck cancer. StrahlentherOnkol 2015;191:43-50.
Joye I, Macq G, Vaes E, Roels S, Lambrecht M, Pelgrims A,Bussels B, Vancleef A, Stellamans K, Scalliet P, Weytjens R, Christian N, Boulanger AS, Donnay L, Van Brussel S, Moretti L, Van den Bergh L, Van Eycken E, Debucquoy A, Haustermans K. Do refined consensus guidelines improve the uniformity of clinical target volume delineation for rectal cancer? Results of a national review project. RadiotherOncol 2016 Aug; 120 (2):202-206.
Dirk De Ruysscher, Kobe Reynders, Evert Van Limbergen, Maarten Lambrecht. Radiotherapy in combination with immune checkpoint inhibitors. Current opinion in Oncology 2017 Jan 12.
De Ruysscher, Dirk; Lambrecht, Maarten; van Baardwijk, Angela; Peeters, Stéphanie; Reymen, Bart; Verhoeven, Karolien; Wanders, Rinus; Öllers, Michel; van Elmpt, Wouter; van Loon, Judith; ,Standard of care in high-dose radiotherapy for localized non-small cell lung cancer,ActaOncologica 2017 ,56,11,1610-1613.
Decaluwe, Herbert; Moons, J; Lambrecht, M; De Wever, W; Coolen, J; Deroose, C; Depypere, L; Van Raemdonck, D; De Leyn, P; Dooms, C; ,P-106SURVIVAL ANALYSIS IN PATIENTS WITH cSTAGE-I SUSPECTED NON-SMALL CELL LUNG CANCER REFERRED TO SURGERY BUT WHO WERE ALSO CANDIDATES FOR STEREOTACTIC BODY RADIATION THERAPY,InteractiveCardioVascular and Thoracic Surgery 2017,25,suppl_1
Frick, AE; Moons, J; Nackaerts, K; Coolen, J; Verbeken, E; Lambrecht, M; Lievens, Y; Coosemans, W; Decaluwé, H; De Leyn, P; ,TrimodalesTherapiekonzeptunterEinschluss der extrapleuralenPneumonektomiebeimalignemPleuramesotheliom: eine single-center Erfahrung,"ZentralblattfürChirurgie-ZeitschriftfürAllgemeine, Viszeral-, Thorax-und Gefäßchirurgie" 2017 ,142,S 01,V 113
Defraene, G; Van Elmpt, W; Lambrecht, M; De Ruysscher, D; ,P3. 14-011 Mean Heart Dose Is an Independent Risk Factor for Early Mortality After Chemoradiotherapy Treatment for Lung Cancer,Journal of Thoracic Oncology 2017; 12,11,S2334-S2335
Decaluwe, H; Moons, J; De Wever, W; Deroose, C; Stanzi, A; Depypere, L; Nackaerts, K; Coolen, J; Lambrecht, M; De Ruysscher, D; ,P1. 13-007 Is Central Lung Tumor Location Really Predictive for Occult Mediastinal Nodal Disease in (Suspected) NSCLC Staged cN0 on PET-CT? Journal of Thoracic Oncology 2017, 12,11,S2034.
Decaluwé, Herbert; Moons, Johnny; Fieuws, Steffen; De Wever, Walter; Deroose, Christophe; Stanzi, Alessia; Depypere, Lieven; Nackaerts, Kristiaan; Coolen, Johan; Lambrecht, Maarten; ,Is central lung tumour location really predictive for occult mediastinal nodal disease in (suspected) non-small-cell lung cancer staged cN0 on 18F-fluorodeoxyglucose positron emission tomography–computed tomography?European Journal of Cardio-Thoracic Surgery,2018,
Eekers, Daniëlle BP; Lambrecht, Maarten; Nyström, Petra De Witt; Swinnen, Ans; Wesseling, Frederik WR; Roelofs, Erik; Troost, Esther GC; ,EPTN consensus-based guideline for the tolerance dose per fraction of organs at risk in the brain,2018. Cancerdata.org
Lambrecht, Maarten; Eekers, Danielle BP; Alapetite, Clair; Burnett, Neil; Calugaru, Valentin; Coremans, Ida; Fossatti, Piero; Høyer, Morten; Langendijk, Johannes; Romero, Alejandra Mendez; Paulsen, Frank; Perpar, Ana; Renard, Laurette; De Ruysscher, Dirk; Timmermann, Beate; Vitek, Pavel; Weber, Damien; Vander Weide, Hiske; Whitfield, Gillian; Wiggenraad, Ruud; Roelofs, Erik; Nystrom, Petra Witte; Troost Esther. Radiation Dose Constraints for organs at risk in neuro-oncology; the European Particle Therapy Network Consensus. Submitted to Radiotherapy & Oncology 2018
Eekers, Danielle BP; In 't Ven, Lieke; Roelofs, Erik; Postma, Alida; Alapetite, Claire; Burnet, Neil; Calugaru, Valentin; Compter, Inge; Coremans, Ida; Hoyer, Morton; Lambrecht, Maarten; Romero, Alejandra Mendez; Paulsen, Frank; Perpar, Ana; De Ruysscher, Dirk; Renard, Laurette; Vitek, Pavel; Weber, Damien C; Van der Weide, Hiske; Whitfield, Gilian; Wiggenraad, Ruud; Nyström, Petra Witt; Timmerman, Beate; Troost, Esther GC; on behalf of the taskforce "European Particle Therapy Network" of ESTRO. The EPTN consensus based atlas for CT- and MR-based contouring in Neuro-Oncology. Accepted for publication in Radiotherapy & Oncology 2018.
3Curriculum Vitae
01-10-2017: ZAP, parttime lecturer at the laboratory of experimental radiotherapy, Department of Oncology, KU Leuven.
01-08-2017: Adjunct Kliniekhoofd department of Radiotherapy–Oncology, UZ Gasthuisberg Leuven
01-08-2017: secretary of the Belgian college of radiotherapy-oncology.
23-09-2016 Good clinical practice certificate
2nd ESTRO AGORA meeting- Future leaders retreat: 10-12/06/2016
Observership proton therapy: 07-03-2016 till 31-03-2016
Supervision: M Baumann and M Krause,
KlinikundpoliklinikfürStrahlentherapieundRadioonkologie
Universitatsklinikum Carl GustafCarus Dresden
Oncoray national center for Radiation Research in Oncology Dresden
Current position: From 01-08-2015: Staff member at Department of Radiotherapy-Oncology
Leuven Kanker Instituut
University Hospitals Leuven
Herestraat 49
3000 Leuven
Specialist in Radiotherapy-oncology: 31-07-2015
PhD in biomedical sciences, KULeuven, 17-12-2013
Topic: Optimizing radiotherapy in head and neck cancer:
Reducing toxicity and exploring the potential of diffusion-weighted MRI
Promotor: prof Sandra Nuyts
Phd Defence: 17-12-2013
Junior Representative in the board of the Belgian society of radiotherapy-oncology ABRO-BVRO. 2013-2014
Research on the role of functional imaging in rectal cancer: 2009-2010
Residency Radiotherapy-Oncology:
2008-2009: Department of Radiation Oncology, University Hospitals Leuven
2013-2014: Service de Radiotherapie, UniversitéCatholique de Louvain
14-06-2014: Official examination Radiotherapy-Oncology:
2014-2015: Department of Radiation Oncology, University Hospitals Leuven
Faculty of Medicine: K.U.Leuven, 2001-2008
Results: Magna cum Laude
Speciality: Radiotherapy-Oncology
Internship:
Internal medicine: AZ Augustinus, Veurne
Surgery: AZ Groeninge, Kortrijk
Gynaecology: Universidad Catolica, Cordoba, Arg
Pediatrics: Universidad Catolica, Cordoba, Arg